New York: Stock comment

22-06-1992 Comments (0)

Abbott LaboratoriesAbciximabActivaseAdalat CCAlbuminAlbuminarAlendronate SodiumAllerganAlphaAlpharmaAlteplaseALZA CorpAmgenAmifostineAmino AcidsAmylinAnakinraAnaproxAnaprox DSAntihemophilic FactorAriceptatorvastatinAvastinAvonexBaxterBaxter Biopharma SolutionsBaxter Healthcare Corporation's BioPharma SolBaxter Healthcare Corporation's BioPharma SolBaxter Healthcare Corporation's BioPharma SolBaxter InternationalBetaseronbevacizumabBiCNUBristol-Myers SquibbBuminate 5%CapotenCaptoprilCardinal HealthCardizem LACarmustineCeclorCefaclorCefadroxilCefadroxil HemihydrateCellCeptCephalonCerubidineCetirizineCidofovirCimetidineClaritinCoagulation Factor VIIaCognexConjugated EstrogensCopaxoneCopegusCozaarCytovenedaclizumabDarifenacin Extended-Release TabletsDaunorubicinDexfenfluramineDilacor XRDiltiazemDiltiazem Hydrochloride CapsuledocetaxeldonepezilDornase alfaDuricefEisaiEldeprylEnablexEnalaprilEnbrelEpivirEpoetin AlfaEpogenEptifibatideEstrogensetanerceptEthyolEvistaExtended ReleaseFelbamateFelbatolFilgrastimfinasterideFlumadineFluoxetine HclFluvastatin SodiumForest LaboratoriesFosamaxGanciclovirgemcitabine HclGemzarGenentechGenzymeGilead SciencesGiliad SciencesGlatiramer AcetateGliadelGuilford PharmaceuticalsHalcionHerceptinHumalogHumulin 70-30Humulin NHumulin RibuprofeninfliximabInjectionInsulinInsulin LisproIntegrilinInterferon alfa-2bInterferon beta-1aInterferon beta-1bIntron AIsis PharmaceuticalsIvaxJohnson & JohnsonKetoprofenKineretLamivudineLescolLeukineLillyLipitorLoratadineLosartan PotassiumLovastatinMedroxyprogesterone Acetate TabletsMenestMerck KGaAMevacorModafinilMonsantoMotrinMycophenolate MofetilMylan LaboratoriesNabumetoneNaprosynNaproxenNeupogenNifedipineNolvadexNorvirNovo NordiskNystatinOlanzapineOmeprazoleOralOral SolutionOrudisPaclitaxelparoxetinePaxilPfizerPharmaciaPharmacyclicsPhysostigmine SalicylatePolifeprosan 20 with CarmustinePremarinPrilosecProcainamideProcan SrProcardiaProcritProcter & GambleProlastinPronestylPropeciaProscarProveraProvigilProzacPulmozymeQuadrametRaloxifeneranitidineRebetolRebifRecombinantRecombinant for InjectionReduxRelafenRemicadeReoProRezulinRibavirinRilutekRiluzoleRimantadineRitonavir CapsulesRocheSamarium SM 153 LexidronamSandozSankyoSargramostimSchering AgSchering PloughSchering-PloughSelegiline HclsildenafilSimvastatinStreptaseStreptokinaseStreptomycinTabloidTacrineTagamettamoxifenTaxolTaxotereThioguaninetrastuzumabTriazolamTroglitazoneVaricella Virus Vaccine LiveVarivaxVasotecViagraVirazoleVistideVitrasertWatson PharmaceuticalsZantacZenapaxZocorZyprexaZyrtec

NEW YORK: lost over 60 points in the first two trading days of the current reporting period, largely…

In order to access this content you need to be logged into the site and have an active subscription or trial subscription.  Please login, take a free trial or subscribe in order to continue reading.

A trial subscription will give you access to the latest news on The Pharma Letter for 7 days, in order to evaluate the paid service.   

Take a Free Trial

What you get

Access The Pharma Letter's latest news free for 7 days

alt

PLUS... you can receive the Pharma Letter headlines and news roundup email free forever

Become a Subscriber

What you get

Unlimited access to The Pharma Letter site for a whole year
Only £70 per month or £720 per year

alt

  • No-limits access to our the site with up-to-the minute news
  • Personalised news and email alerts
  • Online discussion forums and Q&A section
  • RSS news feeds that you can add to your favourite reader, or website
  • Daily news email alert, with the breaking news stories and news roundup

“Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. Its part of the key information for keeping me informed”

Nigel Brooksby, Chairman, Sanofi aventis UK Ltd

Back to top